Showing results (131-140 of 330) with videos related to
Sort By:
Pageof 33
Cardiovascular Diabetology|March 10, 2023
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trialEdward Franek, Prem Pais, Jan Basile, et al.Circulation|November 1, 2015
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With DysglycemiaHertzel C Gerstein, Guillaume Paré, Matthew J McQueen, et al.Journal of Hypertension|December 20, 2012
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trialJohannes F E Mann, Craig Anderson, Peggy Gao, et al.Diabetes Care|March 21, 2025
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 DiabetesGeremia B Bolli, Philip D Home, Francesca Porcellati, et al.Nature Communications|July 27, 2023
Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetesRavi Retnakaran, Jiajie Pu, Alexandra Emery, et al.Diabetes Care|December 15, 2012
Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trialHertzel C Gerstein, Walter T Ambrosius, Ronald Danis, et al.Journal of the American College of Cardiology|May 22, 2010
Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countriesAndrew Mente, Salim Yusuf, Shofiqul Islam, et al.Trends in Molecular Medicine|May 5, 2019
Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic RiskDaniella C Terenzi, Justin Z Trac, Hwee Teoh, et al.Diabetes Care|February 20, 2025
Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or ObesityMatthew M Y Lee, Nazim Ghouri, Anoop Misra, et al.The Journal of Clinical Endocrinology and Metabolism|May 14, 2020
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and DapagliflozinNatalia McInnes, Stephanie Hall, Farah Sultan, et al.Pageof 33